About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Texas | 864 Studies

Clinical Trials Prostate CancerTexas

Prostate Cancer Clinical Trials in Texas

Find 864 clinical trials for prostate cancer near Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 141-160 of 864 trials

CompletedVinflunine in Hormone Refractory Prostate Cancer (HRPC)Currently, there are no established 2nd-line or salvage chemotherapy regimens for patients with HRPC, many of whom retain an excellent performance status.NCT00545766·Fort Myers, Florida and 11 others RecruitingTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsThis phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from…NCT03866382·Birmingham, Alabama and 581 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedA Study of ASP1951 in Subjects With Advanced Solid TumorsThe primary purpose of this study is to evaluate the tolerability and safety profile of ASP1951 when administered as a single agent and in combination with pembrolizumab in…NCT03799003·Tucson, Arizona and 31 others

CompletedPilot Study: Androgen Deprivation Therapy Impact on PSMA-PET Sensitivity in Prostatectomy StagingThis is a pilot, non-randomized, two-cohort interventional study in patients who meet the inclusion criteria, using an FDA- approved androgen deprivation agent for a 3 or 6-week…NCT07069465·Dallas, Texas

UnknownChemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaThe purposes of this study are to determine: * the largest dose of AQ4N that can be safely given once a week for three weeks out of a 4 week cycle * the side effects of AQ4N when…NCT00090727·The Bronx, New York and 1 other

CompletedBicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate CancerThis phase II trial studies how well giving bicalutamide with or without Akt inhibitor MK2206 works in treating patients with previously treated prostate cancer.NCT01251861·Palo Alto, California and 197 others

CompletedA Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active SurveillanceThe primary purpose of this study was to compare the time to prostate cancer progression (pathological or therapeutic progression) between patients treated with enzalutamide…NCT02799745·Birmingham, Alabama and 53 others

RecruitingA Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPCThis is a dose-finding study to assess the safety and preliminary antitumor activity of Pocenbrodib alone or with darolutamide in patients with metastatic castration-resistant…NCT06785636·Fountain Valley, California and 18 others

CompletedA Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation TherapyParticipants who completed the FE200486 CS21 study (NCT00295750) could enter the FE200486 CS21A study.NCT00451958·Homewood, Alabama and 68 others

Active not recruitingTargeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST).The treatment regimen will consist of 4 doses of FPI-2265NCT05219500·Omaha, Nebraska and 1 other

RecruitingA Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate CancerResearchers conducting this study hope to learn about the safety and effectiveness of combining two study drugs, relacorilant and enzalutamide, plus androgen deprivation therapy…NCT05726292·Chicago, Illinois and 3 others

Active not recruitingA Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following SurgeryPatients with post-prostatectomy PSA (Prostate Specific Antigen) recurrences with aggressive disease features will receive salvage radiation therapy and standard androgen…NCT03809000·Gilbert, Arizona and 107 others

Completed"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased RiskThis 4-year study will compare how safe and effective an oral investigational medicine is (compared to placebo) in preventing the development of prostate cancer in men that are…NCT00056407·Birmingham, Alabama and 931 others

Active not recruitingNeoadjuvant Dietary Intervention in Intermediate Risk Prostate CancerThis clinical trial studies the effects of a dietary intervention prior to surgery (neoadjuvant) in patients with intermediate risk prostate cancer.NCT04985565·Houston, Texas

CompletedPROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyPROSTVAC-VF is an investigational cancer vaccine.NCT00078585·Homewood, Alabama and 46 others

TerminatedEfficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting AgentTo demonstrate the efficacy of VERU-111 (Sabizabulin) in the treatment of metastatic castration-resistant prostate cancer in patients who have failed prior treatment with at least…NCT04844749·Anchorage, Alaska and 39 others

RecruitingPROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.1. Personalize treatment for prostate cancer based on how aggressive the disease is and 2.NCT06274047·Gilbert, Arizona and 5 others

CompletedTrial of eRapa in Prostate Cancer PatientsThis study is to determine the safety, pharmacokinetics/pharmacodynamics, and immunologic impact of encapsulated rapamycin in patients with low risk prostate cancer under active…NCT03618355·San Antonio, Texas

UnknownA Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using HypofractionationThe goal of this clinical research study is to compare using external beam radiotherapy with intensity modulated beams for fewer days at a higher dose per day to the same type of…NCT00667888·Houston, Texas

TerminatedTrial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate CancerThis trial represents an attempt to offer second line immunotherapy plus chemotherapy to patients who have failed prior taxane base therapy.NCT00447473·Houston, Texas

PreviousPage 8 of 44Next

Other Conditions in Texas

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma